KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 123 filers reported holding KRYSTAL BIOTECH INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,806 | -48.0% | 15,503 | -48.8% | 0.00% | -50.0% |
| Q2 2023 | $3,471 | +47.5% | 30,300 | 0.0% | 0.01% | +33.3% |
| Q1 2023 | $2,354 | -1.0% | 30,300 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $2,377 | -99.9% | 30,300 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $2,106,000 | +9.9% | 30,300 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $1,916,000 | +13.2% | 30,300 | +19.8% | 0.01% | +50.0% |
| Q1 2022 | $1,693,000 | +173.5% | 25,300 | +187.5% | 0.00% | +100.0% |
| Q4 2021 | $619,000 | +36.6% | 8,800 | +2.3% | 0.00% | +100.0% |
| Q3 2021 | $453,000 | -22.7% | 8,600 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $586,000 | -5.8% | 8,600 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $622,000 | +72.3% | 8,600 | +34.4% | 0.00% | +100.0% |
| Q4 2020 | $361,000 | – | 6,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |